Eric Lefkofsky: The New Hero Fighting Cancer

About 19 million people are expected to have cancer by the year 2024. This is about 5million U.S. citizens who will be affected compared to the year 2014 where 14 million patients were known. It is good we thank God due to the improvements and the rate of progress made by companies like Tempus. Tempus is advocating on the charge of this precision medicine which is data amended. This is digital technology in data collection. This aims at collecting all data about patients and at last making use of the same data to help patients.

Using analytical software, Tempus has developed a platform where molecular and clinical data of a patient is analyzed. This aims at transforming the way cancer patients are treated and take care of. The system aims at giving a streamlined way of corralling information in a useful manner.

Apart from analyzing data Tempus also aimed at changing the way data is collected and stored. There is to form progress notes which have details of patients from day one up to the end. The software was developed to process natural language and recognizes optical characters. All these technologies are meant to make a well-structured data and more information click here.

In addition to that, Tempus is on the run in fighting for the reduction of the cost of conducting human genome sequencing. The process is said to be too expensive. But with the help of Tempus, the prices are expected to be low soon. This process will help the cancer doctors in fighting it from the cellular and molecular level. This can be done by focusing on human genes that contain useful information and his Facebook.

All the above efforts are done by Eric Lefkofsky and Tempus to achieve the best results. It is believed that Eric Lefkofsky is doing this because his wife once had cancer and learn more about Eric.

September 1969 is the birthday of Eric Lefkofsky; he is a native resident of Southfield, Michigan, and graduated from the University of Michigan. He is the owner of Juris Doctor Degree. Eric Lefkofsky is one person who has achieved much in his youthful age. Apart from a core person in Tempus, Eric Lefkofsky holds high administrative positions in organizations like Art Institute of Chicago, and Lurie’s Children’s Memorial Hospital in Chicago just to mention a few.

How Eric Lofkofsky is Helping in the Fight Against Cancer

Statics from the National Cancer Institute indicate that 14.5 million U.S. citizens were living with cancer in 2014.If proper measures are not taken, the figures might rise by over four million, hitting about 19 million by 2024 and more information click here.

However, things might just change for the better, with advances in technologies fronted by companies such as Tempus. The company comes into the picture at a time when Electronic Health Records (EHR) is gaining popularity, though gradually.

With Tempus, clinical information regarding the patient is combined and analyzed with molecular information collected through genome sequencing, to give more accurate and reliable outcome.This detailed interrogation is highly useful as researchers try to make in-depth analysis of cancer at larger.

Eric Lefkofsky, co-founder, and CEO of Tempus, first got an up and close experience with cancer patients when his wife was diagnosed with the disease. The tech-savvy co-founder of another startup, Groupon, was utterly amazed by the gaping holes in the technology used for cancer treatment.An influential figure in tech-matters, Lefkofsky set to build Tempus, which aims at making comprehensive genomic analysis using individual patient’s DNA.Tempus is a foresighted undertaking that will contribute significantly to the treatment of cancer and what Eric knows.

Eric Lefkofsky was born in Southfield, Michigan.The forty-eight-year-old graduated from the University of Michigan in 1991 and earned his Juris Doctor degree the same university two years later.A top academic achiever graduating with honors, Lefkofsky has taught at DePaul University’s Kellstadt Graduate School of Business as well as Northwestern University’s Kellogg School of Management and is presently a professor at the University of Chicago and Eric’s lacrosse camp.

Headquartered in Chicago where Eric Lefkofsky has spent most of his adult life, Tempus is seen as greatly revolutionary, especially at a time when the world stares confusedly at the challenges posed by cancer.

The success of Tempus might add a much-needed relief to the focus that has been given to human molecular and cellular levels as well as genetic composition in the treatment of cancer.Eric Lefkofsky hopes to draw from his previous successes with startups and business in general, to drive Tempus to the next level.

More Visit: https://www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html